Ticker
PRPHCompany Name
PROPHASE LABS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 42.04M | $ -41.45M | -98.6% |
3/31/2025 | $ 50.11M | $ -43.13M | -86.07% |
12/31/2024 | $ 63.2M | $ -53.36M | -84.44% |
9/30/2024 | $ 91.81M | $ -27.76M | -30.23% |
6/30/2024 | $ 93.68M | $ -26.31M | -28.09% |
3/31/2024 | $ 90.03M | $ -23.6M | -26.21% |
12/31/2023 | $ 91.93M | $ -16.78M | -18.26% |
9/30/2023 | $ 91.71M | $ -10.47M | -11.42% |
6/30/2023 | $ 91.06M | $ -4.37M | -4.79% |
3/31/2023 | $ 95.37M | $ 6.52M | 6.84% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for PROPHASE LABS INC is calculated as follows: Net Inc. Cmn. [ $ -1.61M ] / Assets [ $ 23.03M ]
(=) ROA [ -7.01% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.37% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.58% |